PAREXEL International Corporation - Price Analysis Snapshot

This Report features up to a ten-year record of the equity Price history for PAREXEL International Corporation. Tabular results include the High, Low and Closing price for the quarter. There is also a calculation of percentage change in price for both Quarterly and Annual periods. Price values are adjusted for stock splits and dividends.

PAREXEL International Corporation. The Group's principal activities are to provide biopharmaceutical services. The Group operates in three business segments: Clinical Research Services; PAREXEL Consulting and Medical Communications Services and Perceptive Informatics Inc. Clinical Research Services Segment provide clinical trials management and biostatistics, data management and clinical pharmacology services. PAREXEL Consulting and Marketing Services Segment provide technical expertise in disciplines such as drug development, regulatory affairs and biopharmaceutical process and management consulting. Perceptive Segment provides information technology solutions designed to improve clients' product development processes. The Group operates in the United States, Europe, Africa, Asia and other foreign countries. On 14-Aug-2009, the Group acquired ClinPhone plc.

Not the Report you are looking for? Click here for more browsing options.

view sample Single Report

view sample All Basic Reports

Layout and Content of a Typical Report